FDA
approval
· 2024-07-22
FDA Approved: PITAVASTATIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
Summary
FDA approved Upsher-Smith's supplemental application for pitavastatin calcium (pitavastatin) under ANDA205955. This action authorizes the marketing of a generic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PITAVASTATIN (PITAVASTATIN CALCIUM)